Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-018453

Options or other derivatives

  • PRESIDENT & CEO acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MORTIMER IAN PRESIDENT & CEO 2022-03-10 Grant or award · Stock Option (Right to Buy) +400,000 400,000 D
Loading xslF345X03/doc4.xml…